Page last updated: 2024-09-04

atrasentan and Vascular Calcification

atrasentan has been researched along with Vascular Calcification in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Agharazii, M; Gauthier-Bastien, A; Larivière, R; Mac-Way, F; Richard, DE; St-Hilaire, J; Ung, RV	1

Other Studies

1 other study(ies) available for atrasentan and Vascular Calcification

Article	Year
Endothelin type A receptor blockade reduces vascular calcification and inflammation in rats with chronic kidney disease. Journal of hypertension, 2017, Volume: 35, Issue:2 Topics: Animals; Aorta, Thoracic; Atrasentan; Biomarkers; Blood Pressure; Calcium; Calgranulin A; Calgranulin B; Endothelin A Receptor Antagonists; Endothelin-1; Inflammation; Interleukin-1beta; Interleukin-6; Macrophages; Male; Phosphorus, Dietary; Pulse Wave Analysis; Pyrrolidines; Rats; Rats, Wistar; Receptor, Endothelin A; Renal Insufficiency, Chronic; Tumor Necrosis Factor-alpha; Vascular Calcification; Vascular Stiffness; Vitamin D	2017

Article

Year

Endothelin type A receptor blockade reduces vascular calcification and inflammation in rats with chronic kidney disease.

Journal of hypertension, 2017, Volume: 35, Issue:2

Topics: Animals; Aorta, Thoracic; Atrasentan; Biomarkers; Blood Pressure; Calcium; Calgranulin A; Calgranulin B; Endothelin A Receptor Antagonists; Endothelin-1; Inflammation; Interleukin-1beta; Interleukin-6; Macrophages; Male; Phosphorus, Dietary; Pulse Wave Analysis; Pyrrolidines; Rats; Rats, Wistar; Receptor, Endothelin A; Renal Insufficiency, Chronic; Tumor Necrosis Factor-alpha; Vascular Calcification; Vascular Stiffness; Vitamin D

2017